www.fdanews.com/articles/70834-alliance-and-double-crane-announce-memorandum-of-understanding
Alliance and Double-Crane Announce Memorandum of Understanding
April 7, 2005
Alliance Pharmaceutical, through its subsidiary PFC Therapeutics, and Beijing Double-Crane Pharmaceutical ("Double-Crane"), today announced that they have entered into a Memorandum of Understanding ("MOU") for the development of Oxygent in The People's Republic of China ("PRC"). Pursuant to the MOU, the parties intend to negotiate a final license agreement whereby Double-Crane will be granted the right to develop and commercialize Oxygent in the PRC.
BioSpace (http://www.biospace.com/news_story.cfm?StoryID=19613620&full=1)